miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.
miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.
复制标题
DOI:
10.3892/ijo.2018.4252
复制
发表时间:
2018-03
影响因子:
5.2
通讯作者:
Yao S
中科院分区:
文献类型:
--
作者:
Xu M;Xiao J;Chen M;Yuan L;Li J;Shen H;Yao S
Chemotherapeutic resistance remains a critical clinical issue is responsible for treatment failure in patients with ovarian cancer. Evidence of the involvement of miRNAs in chemoresistance in ovarian cancer has been recently emerging. However, the underlying molecular links between chemoresistance and miRNAs remain largely unknown. In this study, we report that miR-149-5p expression is markedly elevated in chemoresistant ovarian cancer tissues compared with the chemosensitive ovarian cancer tissues. Furthermore, the silencing of miR-149-5p enhanced the chemosensitivity of ovarian cancer cells to cisplatin in vitro and in vivo. Conversely, the upregulation of miR-149-5p aggravated chemoresistance in ovarian cancer cells. Our results further revealed that miR-149-5p directly targeted the core kinase components of the Hippo signaling pathway, STE20-like kinase (MST)1 and protein salvador homolog 1 (SAV1), resulting in the inactivation of TEA domain (TEAD) transcription. On the whole, our findings reveal a novel mechanism of of action miR-149-5p in inducing chemotherapeutic resistance in ovarian cancer, indicating that miR-149-5p may serve as a chemotherapeutic response indicator and a potential therapeutic target in ovarian cancer.
登录
查看更多内容
影响因子:
254.7
作者:
Jemal, Ahmedin;Siegel, Rebecca;Thun, Michael J.
通讯作者:
Thun, Michael J.
影响因子:
8
作者:
He C;Lv X;Hua G;Lele SM;Remmenga S;Dong J;Davis JS;Wang C
通讯作者:
Wang C
影响因子:
14.9
作者:
Betel D;Wilson M;Gabow A;Marks DS;Sander C
通讯作者:
Sander C
影响因子:
--
作者:
Fan Q;Cheng Y;Chang HM;Deguchi M;Hsueh AJ;Leung PCK
通讯作者:
Leung PCK
影响因子:
--
作者:
Chen M;Wang M;Xu S;Guo X;Jiang J
通讯作者:
Jiang J